Cardiac Transplantation
📧 Sign up to get email alerts when something new happens for Cardiac Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-25Clinical Trial Update: A Pilot Study Evaluating the Potential of 18F Fluorodeoxyglucose PET-CT Imaging in Diagnosing Cardiac Rejection. [NA]
A pilot study is evaluating whether 18F-FDG PET-CT imaging can help diagnose rejection in heart transplant patients; the trial is not yet re…
-
FDA approval · 2024-07-08FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (CONCORD BIOTECH LIMITED)
FDA approved a supplemental application for Mycophenolate mofetil from Concord Biotech Limited.
-
CLINICAL_TRIALS research · 2016-03-23Clinical Trial Update: Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study
A retrospective multicenter analysis reports 4-year clinical outcomes in subjects previously enrolled in the CTOT-05 cardiac transplantation…
-
CLINICAL_TRIALS trial_result · 2008-12-05Clinical Trial Update: Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC [Phase 2]
Phase 2 trial update for Nesiritide (Natrecor) in transplant-eligible management of congestive heart failure was terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2007-04-27Clinical Trial Update: LOW CYCLO: Study Evaluating the Benefit of Two Doses of Ciclosporine in de Novo Cardiac Transplant [Phase 4]
An update on a Phase 4 study comparing two doses of ciclosporine in patients receiving de novo cardiac transplantation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.